DongKook Pharmaceutical financials at a glance

+ Portfolio

The revenue of DongKook Pharmaceutical is reported as 730.9936 billion Won in the fiscal year 2023. The earnings were 1055 Won per share in 2023, which was 10.82 lower than 2022. And about 39.9733 billion Won are reported as free cash flow in the financials of DongKook Pharmaceutical 2023. Dividends of 180 Won per share were paid to shareholders of DongKook Pharmaceutical stock KOSDAQ:A086450 in fiscal 2023.

₩730.99B

Revenue

₩1.06k

Earnings Per Share

56.16%

Gross Margin %

₩75.80B

Free Cash Flow

Revenue

730,993.60

Earnings Per Share

1,055.00

Gross Margin %

56.16

Free Cash Flow

75,800.00

Financials

Year	Year	TTM	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Rev.	Revenue	N/A	₩730.99B	₩661.65B	₩594.19B	₩559.10B	₩482.28B	₩400.81B	₩354.77B	₩309.63B	₩259.93B	₩226.01B	₩213.09B
GM %	Gross Margin %	56.27%	56.16%	57.38%	58.89%	60.30%	60.23%	59.30%	58.96%	58.95%	57.00%	56.53%	57.60%
OM	Operating Margin	8.94%	9.15%	10.92%	10.64%	14.77%	14.25%	13.75%	14.11%	15.15%	12.93%	11.75%	11.53%
EPS	Earnings Per Share	₩1.06k	₩1.06k	₩1.18k	₩1.13k	₩1.25k	₩1.26k	₩1.06k	₩901.00	₩925.20	₩624.00	₩478.40	₩378.00
Div.	Dividends	N/A	₩180.00	₩186.67	₩180.00	₩180.00	₩160.00	₩0.00	₩80.00	₩60.00	₩60.00	₩60.00	₩0.00
PR %	Payout Ratio %	0	17.06%	15.78%	15.99%	14.39%	12.71%	0	8.88%	6.49%	9.62%	12.54%	0
Sha.	Shares	N/AM	43.96M	43.96M	43.95M	43.95M	43.95M	43.95M	43.95M	43.95M	43.95M	43.97M	44.42M
OCF	Operating Cash Flow	N/A	₩74.15B	₩40.91B	₩44.65B	₩59.11B	₩69.48B	₩0.00M	₩28.66B	₩39.41B	₩27.34B	₩22.74B	₩0.00M
FCF	Free Cash Flow	N/A	₩75.80B	₩-6,262.50M	₩-6,351.93M	₩19.50B	₩44.35B	₩0.00M	₩16.99B	₩25.40B	₩18.28B	₩9.14B	₩0.00M
FCFS	Free Cash Flow Per Share	₩-,109.96	₩50.11	₩-,251.72	₩-,114.27	₩405.34	₩1.01k	₩-4,815.20	₩1.91k	₩3.39k	₩2.02k	₩1.05k	₩1.74k

DongKook Pharmaceutical financials at a glance

Financials

Discover